UROY trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UROY achieves its forward estimates and maintains a stable P/E multiple of 98.3x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 20, 2026, Uranium Royalty Corp. (UROY) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $408M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UROY trades at a trailing P/E of -93.5x and forward P/E of 98.3x. Analysts expect EPS to grow -2.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
RGLDRoyal Gold, Inc. | $14.9B | $214.82 | $330.00 | +53.6% | Buy | 18.8x | 28 |
WPMWheaton Precious Metals Corp. | $55.7B | $122.57 | $170.00 | +38.7% | Buy | 22.7x | 20 |
FNVFranco-Nevada Corporation | $42.3B | $219.26 | $299.00 | +36.4% | Buy | 24.4x | 26 |
EMXEMX Royalty Corporation | $453M | $4.16 | $5.75 | +38.2% | Buy | 45.0x | 1 |
UECUranium Energy Corp. | $5.9B | $12.01 | $20.19 | +68.1% | Buy | — | 8 |
UUUUEnergy Fuels Inc. | $4.1B | $16.58 | $22.33 | +34.7% | Buy | — | 9 |
URGUr-Energy Inc. | $596M | $1.50 | $2.22 | +48.0% | Buy | — | 10 |
DNNDenison Mines Corp. | $3.0B | $3.35 | $4.25 | +26.9% | Buy | — | 8 |
EUenCore Energy Corp. | $320M | $1.65 | $4.17 | +152.7% | Buy | — | 2 |
LTBRLightbridge Corporation | $255M | $9.83 | — | — | — | — | — |
Quick answers to the most common questions about buying UROY stock.
The consensus price target for UROY is $N/A, close to the current price of $2.95 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
UROY has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
At a forward P/E of 98.3333x, UROY trades at a premium valuation. The consensus price target of $N/A (N/A% upside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $N/A for UROY, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
UROY is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UROY stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
UROY trades at a forward P/E ratio of 98.3x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
UROY appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UROY analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.